XT
LAB icon

XTX Topco’s Standard BioTools LAB Stock Holding History

XTX Topco’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$229K Sell
277,826
-51,103
-16% -$48.3K ﹤0.01% 3153
2026
Q1 		$302K Buy
328,929
+122,026
+59% +$148K 0.01% 2472
2025
Q4 		$265K Buy
206,903
+193,909
+1,492% +$260K 0.01% 2181
2025
Q3 		$16.9K Sell
12,994
-83,497
-87% -$109K ﹤0.01% 2358
2025
Q2 		$116K Sell
96,491
-61,596
-39% -$68.3K ﹤0.01% 1853
2025
Q1 		$171K Buy
+158,087
New +$222K 0.01% 1742
2024
Q4 		– Sell
-83,817
Closed -$162K – 2634
2024
Q3 		$162K Buy
83,817
+47,852
+133% +$93.7K 0.01% 1507
2024
Q2 		$63.7K Buy
35,965
+9,947
+38% +$24.3K 0.01% 1482
2024
Q1 		$70.5K Sell
26,018
-112
-0.4% -$270 0.01% 1414
2023
Q4 		$57.7K Buy
+26,130
New +$55.8K 0.01% 1211
2023
Q2 		– Sell
-10,744
Closed -$21K – 1630
2023
Q1 		$21K Sell
10,744
-25,886
-71% -$51.1K ﹤0.01% 1210
2022
Q4 		$42.9K Sell
36,630
-125,226
-77% -$154K 0.01% 1049
2022
Q3 		$178K Buy
161,856
+139,104
+611% +$210K 0.04% 822
2022
Q2 		$36K Buy
+22,752
New +$56.3K 0.01% 776
2021
Q4 		– Sell
-13,690
Closed -$90K – 850
2021
Q3 		$90K Buy
+13,690
New +$90.1K 0.03% 574

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

XTX Topco's LAB Position: Q2 2026 in Review

XTX Topco reduced its Standard BioTools (LAB) stake by 16% in Q2 2026, selling an estimated $48.3K and leaving 277,826 shares worth $229K. The position accounts for ﹤0.01% of the portfolio, ranked #3153.

XTX Topco first reported a position in LAB in Q3 2021 and has held it in 15 quarters since. The position peaked at $302K in Q1 2026. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • XTX Topco held 277,826 shares of Standard BioTools worth $229K as of Q2 2026.
  • XTX Topco sold 51,103 Standard BioTools shares in Q2 2026, an estimated $48.3K.
  • Standard BioTools made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3153 holding.
  • XTX Topco first reported a position in Standard BioTools in Q3 2021 and has held it in 15 quarters since.
  • XTX Topco's Standard BioTools position peaked at $302K in Q1 2026.
  • 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.